EmpowerPharm

EmpowerPharm Awaits Phase 2 Clinical Trial on Ground-Breaking Treatment to Manage Social Anxiety Disorder

First Cannabidiol treatment study of its kind to be approved by the FDA 11 March 2024 -- Ontario, Canada -- EmpowerPharm is delighted to announce that the final participant has completed their treatment in the phase 2 clinical trial assessing the efficacy of pharmaceutical-grade cannabidiol (CBD) for Social Anxiety Disorder. The anticipated release of the top-line...
5575 North Service Road, Suite 603 Burlington, ON, L7L 6M1 Canada

416.291.2580